Is Arzneiwerk VIDA AG halal to invest in?

According to Musaffa's Shariah screening methodology, Arzneiwerk VIDA AG (TLIK.DE) is currently classified as DOUBTFUL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Arzneiwerk VIDA AG a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Arzneiwerk VIDA AG using these criteria to determine its compliance status.

Can Muslims buy shares of Arzneiwerk VIDA AG?

Muslim investors may consider investing in Arzneiwerk VIDA AG if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Arzneiwerk VIDA AG classified as DOUBTFUL?

Musaffa determines the Shariah status of Arzneiwerk VIDA AG by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Arzneiwerk VIDA AG updated?

The Shariah compliance status of Arzneiwerk VIDA AG may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Arzneiwerk VIDA AG become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Arzneiwerk VIDA AG?

You can check the latest Shariah compliance status of Arzneiwerk VIDA AG on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Arzneiwerk VIDA AG TLIK.DE

€0.61

Last Updated: Jun 30, 12:00 AM·XETRA

TLIK.DE Shariah Compliance

Screening Methodology: AAOIFI

DOUBTFUL

Last Updated: July 24, 2025

Report Source: 2024 Annual Report

Arzneiwerk VIDA AG. Stock Analysis TLIK.DE

Germany Health Care Nano Cap Report: 2024 Annual

Arzneiwerk AG VIDA engages in the provision of software development and maintenance of telecommunications solutions for service providers. The company is headquartered in Berlin, Berlin and currently employs 52 full-time employees. The company went IPO on 2007-11-14. The firm is active in the pharmaceutical segment, where it focuses on the growth area of Specialty Pharma in Germany and Europe. Specialty Pharma usually includes high-priced drugs for chronic, complex, or rare diseases. The company focuses on six indication areas: oncology, neurology, autoimmune diseases, ophthalmology, hemophilia, and infectious diseases. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry.

Key Statistics of Arzneiwerk VIDA AG (TLIK.DE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.61€0.61

Today's Open

€0.61

Volume

P/E Ratio (TTM)

52 Week Range

€0.30€0.73

Market Cap

3.65M

Avg. Volume

Dividend Yield

Financial Metrics & Statements of Arzneiwerk VIDA AG (TLIK.DE)

FAQ's for Arzneiwerk VIDA AG (TLIK.DE)

According to Musaffa’s Shariah screening methodology, Arzneiwerk VIDA AG (TLIK.DE) is currently classified as DOUBTFUL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.